JPMorgan Chase & Co’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $291K | Buy |
25,655
+5,398
| +27% | +$61.3K | ﹤0.01% | 4298 |
|
2025
Q1 | $135K | Buy |
20,257
+293
| +1% | +$1.95K | ﹤0.01% | 4601 |
|
2024
Q4 | $220K | Buy |
19,964
+4,512
| +29% | +$49.8K | ﹤0.01% | 4492 |
|
2024
Q3 | $190K | Buy |
15,452
+199
| +1% | +$2.45K | ﹤0.01% | 4475 |
|
2024
Q2 | $206K | Buy |
15,253
+4,309
| +39% | +$58.2K | ﹤0.01% | 4265 |
|
2024
Q1 | $148K | Sell |
10,944
-7,189
| -40% | -$97.1K | ﹤0.01% | 4580 |
|
2023
Q4 | $95.4K | Sell |
18,133
-8,397
| -32% | -$44.2K | ﹤0.01% | 4787 |
|
2023
Q3 | $105K | Buy |
26,530
+3,363
| +15% | +$13.3K | ﹤0.01% | 4579 |
|
2023
Q2 | $246K | Sell |
23,167
-91,300
| -80% | -$971K | ﹤0.01% | 4170 |
|
2023
Q1 | $954K | Buy |
114,467
+90,608
| +380% | +$755K | ﹤0.01% | 3474 |
|
2022
Q4 | $220K | Buy |
23,859
+291
| +1% | +$2.68K | ﹤0.01% | 4166 |
|
2022
Q3 | $302K | Buy |
23,568
+1,070
| +5% | +$13.7K | ﹤0.01% | 3990 |
|
2022
Q2 | $297K | Buy |
22,498
+2,890
| +15% | +$38.2K | ﹤0.01% | 4143 |
|
2022
Q1 | $412K | Buy |
19,608
+3,374
| +21% | +$70.9K | ﹤0.01% | 4114 |
|
2021
Q4 | $390K | Buy |
16,234
+1,506
| +10% | +$36.2K | ﹤0.01% | 4206 |
|
2021
Q3 | $375K | Buy |
14,728
+983
| +7% | +$25K | ﹤0.01% | 4106 |
|
2021
Q2 | $463K | Buy |
13,745
+4,156
| +43% | +$140K | ﹤0.01% | 4045 |
|
2021
Q1 | $373K | Buy |
9,589
+3,573
| +59% | +$139K | ﹤0.01% | 4194 |
|
2020
Q4 | $373K | Buy |
6,016
+1,462
| +32% | +$90.6K | ﹤0.01% | 3908 |
|
2020
Q3 | $156K | Sell |
4,554
-137
| -3% | -$4.69K | ﹤0.01% | 3848 |
|
2020
Q2 | $112K | Sell |
4,691
-814
| -15% | -$19.4K | ﹤0.01% | 3917 |
|
2020
Q1 | $126K | Buy |
5,505
+2,486
| +82% | +$56.9K | ﹤0.01% | 3877 |
|
2019
Q4 | $86K | Buy |
3,019
+18
| +0.6% | +$513 | ﹤0.01% | 4080 |
|
2019
Q3 | $64K | Buy |
+3,001
| New | +$64K | ﹤0.01% | 4149 |
|